3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
14
Thoracic
4
Head & Neck
4
Lymphoid
3
Gynecologic
3
Genitourinary
3
Gastrointestinal
3
Breast
3
Sarcoma
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
7
Thyroid Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thyroid Diseases
2
Thyroid Cancer, Papillary
2
Thoracic Neoplasms
2
Sarcoma
2
Salivary Gland Neoplasms
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Pheochromocytoma
2
Paraganglioma
2
Neuroectodermal Tumors
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Neoplasms
2
Lung Neoplasms
2
Lung Diseases
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Gastrointestinal Neoplasms
2
Gastrointestinal Diseases
2
Endocrine System Diseases
2
Endocrine Gland Neoplasms
2
Digestive System Neoplasms
2
Colonic Neoplasms
2
Colonic Diseases
2
Interventions
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Melanoma
×
NET
×
Clear all
NCT02568267
2026-05-27
STARTRK-2
Hoffmann-La Roche
Phase 2
Active not recruiting
534 enrolled
1 FDA